Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Carolina Lopes, Joana Cristóvão, Vânia Silvério, Paulo Roque Lino & Pedro Fonte. (2022) Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications. Expert Opinion on Drug Delivery 19:10, pages 1381-1395.
Read now
Read now
He Bao, Nanbo Zheng, Zhuanting Li & Yuan Zhi. (2020) Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers. Drug Design, Development and Therapy 14, pages 3057-3068.
Read now
Read now
Man Xu, Guangmeng Li, Haoxiang Zhang, Xiaoming Chen, Yi Li, Qianming Yao & Maobin Xie. (2020) Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect. Drug Delivery 27:1, pages 983-995.
Read now
Read now
Chengsong Cao, Qun Wang & Yong Liu. (2019) Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers. Drug Design, Development and Therapy 13, pages 1087-1098.
Read now
Read now
Jicai Zhang, Xiang Xiao, Jianming Zhu, Ziyun Gao, Xianliang Lai, Xingen Zhu & Guohua Mao. (2018) Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy. International Journal of Nanomedicine 13, pages 3039-3051.
Read now
Read now
Jigar Vanza, Parva Jani, Nilima Pandya & Hemal Tandel. (2018) Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design. Drug Development and Industrial Pharmacy 44:6, pages 923-933.
Read now
Read now
Liuxiang Chu, Aiping Wang, Ling Ni, Xiuju Yan, Yina Song, Mingyu Zhao, Kaoxiang Sun, Hongjie Mu, Sha Liu, Zimei Wu & Chunyan Zhang. (2018) Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting. Drug Delivery 25:1, pages 1634-1641.
Read now
Read now
Yue Zhang, Meifang Zhai, Zhijiang Chen, Xiaoyang Han, Fanglin Yu, Zhiping Li, Xiangyang Xie, Cuiyan Han, Lian Yu, Yang Yang & Xingguo Mei. (2017) Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma. Drug Delivery 24:1, pages 1045-1055.
Read now
Read now
Jiying Yang, Zengjuan Ju & Shufang Dong. (2017) Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer. Drug Delivery 24:1, pages 792-799.
Read now
Read now
Jie Qu, Liangqiao Zhang, Zhihua Chen, Guohua Mao, Ziyun Gao, Xianliang Lai, Xingen Zhu & Jianming Zhu. (2016) Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?. Drug Delivery 23:9, pages 3408-3416.
Read now
Read now
Articles from other publishers (60)
Luisa Ribeiro Nicoleti, Leonardo Delello Di Filippo, Jonatas Lobato Duarte, Marcela Tavares Luiz, Rafael Miguel Sábio & Marlus Chorilli. (2023) Development, characterization and in vitro cytotoxicity of kaempferol-loaded nanostructured lipid carriers in glioblastoma multiforme cells. Colloids and Surfaces B: Biointerfaces 226, pages 113309.
Crossref
Crossref
Tanisha Gupta, Rakesh K. Sahoo, Himani Singh, Sumeet Katke, Akash Chaurasiya & Umesh Gupta. (2023) Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities. AAPS PharmSciTech 24:4.
Crossref
Crossref
Pablo Graván, Aixa Aguilera-Garrido, Juan Antonio Marchal, Saúl A. Navarro-Marchal & Francisco Galisteo-González. (2023) Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment. Advances in Colloid and Interface Science 314, pages 102871.
Crossref
Crossref
Jordan Cossu, Fabien Thoreau & Didier Boturyn. (2023) Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues. Pharmaceutics 15:2, pages 525.
Crossref
Crossref
Jivesh Garg, Khushboo Pathania, Sangeeta Pilkhwal Sah & Sandip V. Pawar. (2022) Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Crossref
Margarita E. Neganova, Yulia R. Aleksandrova, Olga A. Sukocheva & Sergey G. Klochkov. (2022) Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Seminars in Cancer Biology 86, pages 805-833.
Crossref
Crossref
Dovydas Gečys, Arūnas Kazlauskas, Emilija Gečytė, Neringa Paužienė, Deimantė Kulakauskienė, Indrė Lukminaitė & Aistė Jekabsone. (2022) Internalisation of RGD-Engineered Extracellular Vesicles by Glioblastoma Cells. Biology 11:10, pages 1483.
Crossref
Crossref
Reena Jatyan, Prabhjeet Singh, Deepak Kumar Sahel, Y.G. Karthik, Anupama Mittal & Deepak Chitkara. (2022) Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme. Journal of Controlled Release 350, pages 494-513.
Crossref
Crossref
Jason Thomas Duskey, Arianna Rinaldi, Ilaria Ottonelli, Riccardo Caraffi, Chiara Alessia De Benedictis, Ann Katrin Sauer, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi & Andreas Martin Grabrucker. (2022) Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics 14:7, pages 1450.
Crossref
Crossref
Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Alberto Gomes Tavares Junior, Leonardo Delello Di Filippo, Suzana Gonçalves Carvalho & Marlus Chorilli. (2022) Temozolomide: An Overview of Biological Properties, Drug Delivery Nanosystems,
and Analytical Methods. Current Pharmaceutical Design 28:25, pages 2073-2088.
Crossref
Crossref
Wiam El Kheir, Bernard Marcos, Nick Virgilio, Benoit Paquette, Nathalie Faucheux & Marc-Antoine Lauzon. (2022) Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment. Pharmaceutics 14:6, pages 1189.
Crossref
Crossref
Daria Petrenko, Vladimir Chubarev, Nikita Syzrantsev, Nafeeza Ismail, Vadim Merkulov, Susanna Sologova, Ekaterina Grigorevskikh, Elena Smolyarchuk & Renad Alyautdin. (2022) Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems. Molecules 27:11, pages 3507.
Crossref
Crossref
Yining Xu, Thibaut Fourniols, Yasmine Labrak, Véronique Préat, Ana Beloqui & Anne des Rieux. (2022) Surface Modification of Lipid-Based Nanoparticles. ACS Nano 16:5, pages 7168-7196.
Crossref
Crossref
Bwalya Angel Witika, Madan Sai Poka, Patrick Hulisani Demana, Scott Kaba Matafwali, Siyabonga Melamane, Sandile Maswazi Malungelo Khamanga & Pedzisai Anotida Makoni. (2022) Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date. Pharmaceutics 14:4, pages 836.
Crossref
Crossref
Yi-Shu Zhou, Wei Wang, Na Chen, Li-Cui Wang & Jin-Bai Huang. (2022) Research progress of anti-glioma chemotherapeutic drugs (Review). Oncology Reports 47:5.
Crossref
Crossref
Srinivas Reddy Jitta & Lalit Kumar. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors
269
297
.
Iara Baldim, Wanderley P. Oliveira, Rekha Rao, Singh Raghuvir, Sheefali Mahant, Francisco M. Gama & Eliana B. Souto. 2022. Nanoparticle Therapeutics. Nanoparticle Therapeutics
211
246
.
Manasa Manjunath Hegde, Suma Prabhu, Srinivas Mutalik, Abhishek Chatterjee, Jayant S. Goda & B. S. Satish Rao. (2021) Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches. Journal of Pharmaceutical Investigation 52:1, pages 49-74.
Crossref
Crossref
Dorra Aissaoui-Zid, Mohamed-Chiheb Saada, Wassim Moslah, Marie Potier-Cartereau, Aude Lemettre, Houcemeddine Othman, Marc Gaysinski, Zaineb Abdelkafi-Koubaa, Soumaya Souid, Naziha Marrakchi, Christophe Vandier, Khadija Essafi-Benkhadir & Najet Srairi-Abid. (2021) AaTs-1: A Tetrapeptide from Androctonus australis Scorpion Venom, Inhibiting U87 Glioblastoma Cells Proliferation by p53 and FPRL-1 Up-Regulations. Molecules 26:24, pages 7610.
Crossref
Crossref
Gustavo Henrique Rodrigues da Silva, Ludmilla David de Moura, Fabíola Vieira de Carvalho, Gabriela Geronimo, Talita Cesarim Mendonça, Fernando Freitas de Lima & Eneida de Paula. (2021) Antineoplastics Encapsulated in Nanostructured Lipid Carriers. Molecules 26:22, pages 6929.
Crossref
Crossref
Leonardo Delello Di Filippo, Juliana Hofstätter Azambuja, Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Jonatas Lobato Duarte, Luiza Ribeiro Nicoleti, Sara Teresinha Olalla Saad & Marlus Chorilli. (2021) Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 76-89.
Crossref
Crossref
Hamdi Nsairat, Dima Khater, Fadwa Odeh, Fedaa Al-Adaileh, Suma Al-Taher, Areej M. Jaber, Walhan Alshaer, Abeer Al Bawab & Mohammad S. Mubarak. (2021) Lipid nanostructures for targeting brain cancer. Heliyon 7:9, pages e07994.
Crossref
Crossref
Md. Rizwanullah, Mohammad Zaki Ahmad, Anuj Garg & Javed Ahmad. (2021) Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:9, pages 129936.
Crossref
Crossref
P. Soma Yasaswi, Karishma Shetty & Khushwant S. Yadav. (2021) Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy. Journal of Controlled Release 336, pages 549-571.
Crossref
Crossref
Kimmy Tran, Ryan Brice & Li Yao. (2021) Bioscaffold-based study of glioblastoma cell behavior and drug delivery for tumor therapy. Neurochemistry International 147, pages 105049.
Crossref
Crossref
Raúl Ortiz, Gloria Perazzoli, Laura Cabeza, Cristina Jiménez-Luna, Raquel Luque, Jose Prados & Consolación Melguizo. (2021) Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications. Current Neuropharmacology 19:4, pages 513-537.
Crossref
Crossref
Md. Habban Akhter, Md. Rizwanullah, Javed AhmadSaima Amin, Mohammad Zaki AhmadMd. Akram Minhaj, Md. Ali Mujtaba & Javed Ali. (2020) Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme. Drug Research 71:03, pages 122-137.
Crossref
Crossref
Nerea Iturrioz-Rodríguez, Rosalia Bertorelli & Gianni Ciofani. (2020) Lipid‐Based Nanocarriers for The Treatment of Glioblastoma. Advanced NanoBiomed Research 1:2.
Crossref
Crossref
Tatyana Alexandrovna Bogoyavlenskaya, Ekaterina Evgenyevna Tyagunova, Roman Konstantinovich Kostin, Alexander Sergeevich Zaharov, Yuriy Leonidovich Vasil'ev & Olesya Vasilevna Kytko. (2021) Glioblastoma Break-in; Try Something New. International Journal of Cancer Management 14:1.
Crossref
Crossref
Vikas Jain, Hitesh Kumar, Pallavi Chand, Sourabh Jain & Preethi S. 2021. Nanopharmaceutical Advanced Delivery Systems. Nanopharmaceutical Advanced Delivery Systems
1
29
.
Vinitha Rani, Jayachandran Venkatesan & Ashwini Prabhu. 2021. Nanotechnology in Medicine. Nanotechnology in Medicine
123
139
.
Maria Mendes, Tânia Cova, João Basso, M. Luísa Ramos, Rui Vitorino, João Sousa, Alberto Pais & Carla Vitorino. (2020) Hierarchical design of hyaluronic acid-peptide constructs for glioblastoma targeting: Combining insights from NMR and molecular dynamics simulations. Journal of Molecular Liquids 315, pages 113774.
Crossref
Crossref
Raneem Jnaidi, António José Almeida & Lídia M. Gonçalves. (2020) Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme. Pharmaceutics 12:9, pages 860.
Crossref
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2020) Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases. Journal of the Taiwan Institute of Chemical Engineers 114, pages 12-23.
Crossref
Crossref
Sonia M Lombardo, Marc Schneider, Akif E Türeli & Nazende Günday Türeli. (2020) Key for crossing the BBB with nanoparticles: the rational design. Beilstein Journal of Nanotechnology 11, pages 866-883.
Crossref
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2020) Biomaterial-based drug delivery systems used to improve chemotherapeutic activity of pharmaceuticals and to target inhibitors of apoptosis proteins. Journal of the Taiwan Institute of Chemical Engineers 111, pages 1-10.
Crossref
Crossref
Maryanne Trafani de Melo, Henrique Luis Piva & Antonio Claudio Tedesco. (2020) Design of new protein drug delivery system (PDDS) with photoactive compounds as a potential application in the treatment of glioblastoma brain cancer. Materials Science and Engineering: C 110, pages 110638.
Crossref
Crossref
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sunil Kumar Dubey, Anu Puri, Ravish J. Patel, Ajazuddin, V. Ravichandiran, Upadhyayula Suryanarayana Murty & Amit Alexander. (2020) Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. Journal of Controlled Release 321, pages 372-415.
Crossref
Crossref
Irfan Ullah, Kunho Chung, Sumin Bae, Yan Li, Chunggu Kim, Boyoung Choi, Hye Yeong Nam, Sun Hwa Kim, Chae-Ok Yun, Kuen Yong Lee, Priti Kumar & Sang-Kyung Lee. (2020) Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma. Molecular Pharmaceutics 17:4, pages 1193-1204.
Crossref
Crossref
Alfonso Toro-Córdova, Beatriz Sanz & Gerardo F. Goya. (2020) A Concise Review of Nanomaterials for Drug Delivery and Release. Current Nanoscience 16:3, pages 399-412.
Crossref
Crossref
Fakhara Sabir, Ruba Ismail & Ildiko Csoka. (2020) Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook. Drug Discovery Today 25:1, pages 185-194.
Crossref
Crossref
Jessica Silva, João Basso, Maria Mendes, João Sousa, Alberto Pais & Carla Vitorino. 2020. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents
141
182
.
Bibhash C. Mohanta, Narahari N. Palei, Vijayaraj Surendran, Subas C. Dinda, Jayaraman Rajangam, Jyotirmoy Deb & Biswa M. Sahoo. (2019) Lipid Based Nanoparticles: Current Strategies for Brain Tumor Targeting. Current Nanomaterials 4:2, pages 84-100.
Crossref
Crossref
Gang Zheng, Meizhu Zheng, Ben Yang, Hui Fu & Yongqing Li. (2019) Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Biomedicine & Pharmacotherapy 116, pages 109006.
Crossref
Crossref
Juhi Samal, Ana Lucia Rebelo & Abhay Pandit. (2019) A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders. Advanced Drug Delivery Reviews 148, pages 68-145.
Crossref
Crossref
Alja Zottel, Alja Videtič Paska & Ivana Jovčevska. (2019) Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy. Materials 12:10, pages 1588.
Crossref
Crossref
Xiaolei Cai, Aishwarya Bandla, Chan Kim Chuan, Gayathiri Magarajah, Lun-De Liao, Daniel Boon Loong Teh, Brian K. Kennedy, Nitish V. Thakor & Bin Liu. (2019)
Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient
in vivo
fluorescence image-guided photothermal therapy
. Materials Horizons 6:2, pages 311-317.
Crossref
Crossref
Josef Jampílek & Katarína Kráľová. 2019. Nanoarchitectonics in Biomedicine. Nanoarchitectonics in Biomedicine
219
294
.
Rijo John, Heero Vaswani, Prajakta Dandekar & Padma V. Devarajan. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
45
78
.
Yan Zou, Yanjie Liu, Zhipeng Yang, Dongya Zhang, Yiqing Lu, Meng Zheng, Xue Xue, Jia Geng, Roger Chung & Bingyang Shi. (2018) Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine. Advanced Materials 30:51, pages 1803717.
Crossref
Crossref
Jessica Silva, Maria Mendes, Tânia Cova, João Sousa, Alberto Pais & Carla Vitorino. (2018) Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles. AAPS PharmSciTech 19:5, pages 2383-2394.
Crossref
Crossref
Lakshmi Pallavi Ganipineni, Fabienne Danhier & Véronique Préat. (2018) Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment. Journal of Controlled Release 281, pages 42-57.
Crossref
Crossref
Archana Khosa, Satish Reddi & Ranendra N. Saha. (2018) Nanostructured lipid carriers for site-specific drug delivery. Biomedicine & Pharmacotherapy 103, pages 598-613.
Crossref
Crossref
Narahari N. Palei, Bibhash C. Mohanta, Mohana L. Sabapathi & Malay K. Das. 2018. Organic Materials as Smart Nanocarriers for Drug Delivery. Organic Materials as Smart Nanocarriers for Drug Delivery
415
470
.
Maria J. Ramalho, Manuel A.N. Coelho & Maria C. Pereira. 2018. Design and Development of New Nanocarriers. Design and Development of New Nanocarriers
687
722
.
Masoumeh Mansoubi Hosseini, Aliasghar Karimi, Mitra Behroozaghdam, Mohammad Amin Javidi, Saeedeh Ghiasvand, Ahmad Bereimipour, Hoda Aryan, Farbod Nassiri & Ehsan Jangholi. (2017) Cytotoxic and Apoptogenic Effects of Cyanidin-3-Glucoside on the Glioblastoma Cell Line. World Neurosurgery 108, pages 94-100.
Crossref
Crossref
Pablo Játiva & Valentín Ceña. (2017) Use of nanoparticles for glioblastoma treatment: a new approach. Nanomedicine 12:20, pages 2533-2554.
Crossref
Crossref
Ana Miranda, María J Blanco-Prieto, João Sousa, Alberto Pais & Carla Vitorino. (2017) Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles. International Journal of Pharmaceutics 531:1, pages 389-410.
Crossref
Crossref
Saurabh Sharma, Kishan Italiya, Anupama Mittal & Deepak Chitkara. (2017) New strategies for cancer management: how can temozolomide carrier modifications improve its delivery?. Therapeutic Delivery 8:7, pages 475-477.
Crossref
Crossref
Chang Hyun Kim, Sang Gon Lee, Myung Joo Kang, Sangkil Lee & Young Wook Choi. (2017) Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting. Journal of Pharmaceutical Investigation 47:3, pages 203-227.
Crossref
Crossref